Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) represent rare types of myocardial inflammation frequently associated with ventricular tachycardia and advanced types of atrioventricular block (AVB). The majority of patients with GCM either die or undergo heart transplantation unless combined immunosuppressive therapy is administered early in the course of the disease.